Cargando…
The Clinical Potential of IL-12/IL-35 in Treating Chemotherapy Drug-induced Cardiac Injury
Autor principal: | Jia, Zhanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156735/ https://www.ncbi.nlm.nih.gov/pubmed/30143465 http://dx.doi.org/10.1016/j.ebiom.2018.08.018 |
Ejemplares similares
-
The clinical potential of IL-12/IL-35 in treating chemotherapy drug-induced cardiac injury – Authors' reply
por: Ye, Jing, et al.
Publicado: (2018) -
IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease
por: Dambuza, Ivy M., et al.
Publicado: (2017) -
IL-12– and IL-23–induced T helper cell subsets: birds of the same feather flock together
por: Bettelli, Estelle, et al.
Publicado: (2005) -
Recombinant p35 from Bacteria Can Form Interleukin (IL-)12, but Not IL-35
por: Aparicio-Siegmund, Samadhi, et al.
Publicado: (2014) -
Human IL-35 Inhibits the Bioactivity of IL-12 and Its Interaction with IL-12Rβ2
por: Mahfooz, Najmus S., et al.
Publicado: (2023)